Drugs / GLIQUIDONE
GLIQUIDONE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00568074 | Dec 2003 → Sep 2004 | type 2 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GLIQUIDONE | ChEMBL registry synonym — accepted as the source's own label CHEMBL383634 ↗ |
| Known as | ARDF 26 | ChEMBL registry synonym — accepted as the source's own label CHEMBL383634 ↗ |
| Known as | Gliquidona | ChEMBL registry synonym — accepted as the source's own label CHEMBL383634 ↗ |
| Known as | Glurenorm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00568074 ↗ |
| Modality | Small molecule | — CHEMBL383634 ↗ |